Sfoglia per Rivista LEUKEMIA
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
2004-01-01 Cuneo, A; Rigolin, Gm; Bigoni, R; De Angeli, C; Veronese, A; Cavazzini, F; Bardi, A; Roberti, Mg; Tammiso, E; Agostini, P; Ciccone, M; Tieghi, A; Cavazzini, L; Negrini, M; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
2001-01-01 Rigolin, Gm; Bigoni, R; Milani, R; Cavazzini, F; Roberti, Mg; Bardi, A; Agostini, P; Tieghi, A; Piva, N; Cuneo, A; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
2019-01-01 Todisco, Gabriele
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms
2021-01-01 Todisco, Gabriele
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised international prognostic scoring system (IPSS-R)
2017-01-01 Della Porta, M; Jackson, Ch; Alessandrino, Ep; Rossi, M; Bacigalupo, A; van Lint, Mt; Bernardi, M; Allione, B; Bosi, A; Guidi, S; Santini, V; Malcovati, L; Ubezio, M; Milanesi, C; Todisco, E; Voso, Mt; Musto, P; Onida, F; Iori, Ap; Cerretti, R; Grillo, G; Molteni, A; Pioltelli, P; Borin, L; Angelucci, E; Oldani, E; Sica, S; Pascutto, C; Ferretti, V; Santoro, A; Bonifazi, F; Cazzola, M; Rambaldi, A.
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
2010-01-01 DELLA PORTA, MATTEO GIOVANNI
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts
2003-01-01 Lunghi, P.; Tabilio, A.; Dall'Aglio, P. P.; Ridolo, E.; Carlo-Stella, C.; Pelicci, P. G.; Bonati, A.
EFFECTS OF DESFERRIOXAMINE ON NORMAL AND LEUKEMIC HUMAN HEMATOPOIETIC-CELL GROWTH - INVITRO AND INVIVO STUDIES
1989-01-01 Dezza, L; Cazzola, M; Danova, M; CARLO STELLA, C.; Bergamaschi, G; Brugnatelli, S; Invernizzi, R; Mazzini, G; Riccardi, A; Ascari, E
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
2022-01-01 Zeidan, Amer M; Bewersdorf, Jan Philipp; Buckstein, Rena; Sekeres, Mikkael A; Steensma, David P; Platzbecker, Uwe; Loghavi, Sanam; Boultwood, Jacqueline; Bejar, Rafael; Bennett, John M; Borate, Uma; Brunner, Andrew M; Carraway, Hetty; Churpek, Jane E; Daver, Naval G; Della Porta, Matteo; Dezern, Amy E; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E; Greenberg, Peter; Griffiths, Elizabeth A; Halene, Stephanie; Hasserjian, Robert P; Hourigan, Christopher S; Kim, Nina; Kim, Tae Kon; Komrokji, Rami S; Kutchroo, Vijay; List, Alan F; Little, Richard F; Majeti, Ravi; Nazha, Aziz; Nimer, Stephen D; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M; Roboz, Gail J; Sallman, David A; Sanz, Guillermo; Stahl, Maximilian; Starczynowski, Daniel T; Taylor, Justin; Xie, Zhuoer; Xu, Mina; Savona, Michael R; Wei, Andrew H; Abdel-Wahab, Omar; Santini, Valeria
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome
2005-01-01 DELLA PORTA, MATTEO GIOVANNI
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
2006-01-01 DELLA PORTA, MATTEO GIOVANNI
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
2010-01-01 DELLA PORTA, MATTEO GIOVANNI
GROWTH OF CD34+ ACUTE MYELOBLASTIC-LEUKEMIA COLONY-FORMING CELLS IN RESPONSE TO RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS
1990-01-01 CARLO-STELLA, C.; Mangoni, L; Almici, C; Frassoni, F; Fiers, W; Rizzoli, V
GROWTH OF HUMAN HEMATOPOIETIC COLONIES FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN RESPONSE TO RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
1989-01-01 CARLO STELLA, C.; Cazzola, M; Bergamaschi, G; Bernasconi, P; Dezza, L; Invernizzi, R; Pedrazzoli, P
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study
2016-01-01 Lacombe, F; Bernal, E; Bloxham, D; Couzens, S; Della Porta, M; Johansson, U; Kern, W; Macey, M; Matthes, T; Morilla, R; Paiva, A; Palacio, C; Preijers, F; Ratei, R; Siitonen, S; Allou, K; Porwit, A; Béné, Mc
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes.
2008-01-01 DELLA PORTA, MATTEO GIOVANNI
Inflammation and multiple myeloma: the Toll connection.
2006-01-01 Mantovani, A; Garlanda, C
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF
2005-01-01 Ricca, I.; Compagno, M.; Ladetto, M.; Rocci, A.; Dell'Aquila, M.; Omedè, P.; De Marco, F.; D'Antico, S.; Caracciolo, D.; Ferrero, D.; Carlo-Stella, C.; Tarella, C.
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
2015-01-01 DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Boveri, E; Ponzoni, M; Malcovati, Luca; Papaemmanuil, E; Rigolin, Gm; Pascutto, C; Croci, G; Gianelli, U; Milani, R; Ambaglio, I; Elena, Chiara; Ubezio, M; Da Via', Mc; Bono, E; Pietra, D; Quaglia, F; Bastia, R; Ferretti, V; Cuneo, A; Morra, E; Campbell, Pj; Orazi, A; Invernizzi, Rosangela; Cazzola, Mario
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest.
2016-01-01 Locatelli, S L; Careddu, G; Inghirami, G; Castagna, L; Sportelli, P; Santoro, A; Carlo-Stella, C
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. | 1-gen-2004 | Cuneo, A; Rigolin, Gm; Bigoni, R; De Angeli, C; Veronese, A; Cavazzini, F; Bardi, A; Roberti, Mg; Tammiso, E; Agostini, P; Ciccone, M; Tieghi, A; Cavazzini, L; Negrini, M; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI | |
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. | 1-gen-2001 | Rigolin, Gm; Bigoni, R; Milani, R; Cavazzini, F; Roberti, Mg; Bardi, A; Agostini, P; Tieghi, A; Piva, N; Cuneo, A; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI | |
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome | 1-gen-2019 | Todisco, Gabriele | |
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms | 1-gen-2021 | Todisco, Gabriele | |
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised international prognostic scoring system (IPSS-R) | 1-gen-2017 | Della Porta, M; Jackson, Ch; Alessandrino, Ep; Rossi, M; Bacigalupo, A; van Lint, Mt; Bernardi, M; Allione, B; Bosi, A; Guidi, S; Santini, V; Malcovati, L; Ubezio, M; Milanesi, C; Todisco, E; Voso, Mt; Musto, P; Onida, F; Iori, Ap; Cerretti, R; Grillo, G; Molteni, A; Pioltelli, P; Borin, L; Angelucci, E; Oldani, E; Sica, S; Pascutto, C; Ferretti, V; Santoro, A; Bonifazi, F; Cazzola, M; Rambaldi, A. | |
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. | 1-gen-2010 | DELLA PORTA, MATTEO GIOVANNI | |
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts | 1-gen-2003 | Lunghi, P.; Tabilio, A.; Dall'Aglio, P. P.; Ridolo, E.; Carlo-Stella, C.; Pelicci, P. G.; Bonati, A. | |
EFFECTS OF DESFERRIOXAMINE ON NORMAL AND LEUKEMIC HUMAN HEMATOPOIETIC-CELL GROWTH - INVITRO AND INVIVO STUDIES | 1-gen-1989 | Dezza, L; Cazzola, M; Danova, M; CARLO STELLA, C.; Bergamaschi, G; Brugnatelli, S; Invernizzi, R; Mazzini, G; Riccardi, A; Ascari, E | |
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes | 1-gen-2022 | Zeidan, Amer M; Bewersdorf, Jan Philipp; Buckstein, Rena; Sekeres, Mikkael A; Steensma, David P; Platzbecker, Uwe; Loghavi, Sanam; Boultwood, Jacqueline; Bejar, Rafael; Bennett, John M; Borate, Uma; Brunner, Andrew M; Carraway, Hetty; Churpek, Jane E; Daver, Naval G; Della Porta, Matteo; Dezern, Amy E; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E; Greenberg, Peter; Griffiths, Elizabeth A; Halene, Stephanie; Hasserjian, Robert P; Hourigan, Christopher S; Kim, Nina; Kim, Tae Kon; Komrokji, Rami S; Kutchroo, Vijay; List, Alan F; Little, Richard F; Majeti, Ravi; Nazha, Aziz; Nimer, Stephen D; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M; Roboz, Gail J; Sallman, David A; Sanz, Guillermo; Stahl, Maximilian; Starczynowski, Daniel T; Taylor, Justin; Xie, Zhuoer; Xu, Mina; Savona, Michael R; Wei, Andrew H; Abdel-Wahab, Omar; Santini, Valeria | |
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome | 1-gen-2005 | DELLA PORTA, MATTEO GIOVANNI | |
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. | 1-gen-2006 | DELLA PORTA, MATTEO GIOVANNI | |
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. | 1-gen-2010 | DELLA PORTA, MATTEO GIOVANNI | |
GROWTH OF CD34+ ACUTE MYELOBLASTIC-LEUKEMIA COLONY-FORMING CELLS IN RESPONSE TO RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS | 1-gen-1990 | CARLO-STELLA, C.; Mangoni, L; Almici, C; Frassoni, F; Fiers, W; Rizzoli, V | |
GROWTH OF HUMAN HEMATOPOIETIC COLONIES FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN RESPONSE TO RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR | 1-gen-1989 | CARLO STELLA, C.; Cazzola, M; Bergamaschi, G; Bernasconi, P; Dezza, L; Invernizzi, R; Pedrazzoli, P | |
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study | 1-gen-2016 | Lacombe, F; Bernal, E; Bloxham, D; Couzens, S; Della Porta, M; Johansson, U; Kern, W; Macey, M; Matthes, T; Morilla, R; Paiva, A; Palacio, C; Preijers, F; Ratei, R; Siitonen, S; Allou, K; Porwit, A; Béné, Mc | |
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. | 1-gen-2008 | DELLA PORTA, MATTEO GIOVANNI | |
Inflammation and multiple myeloma: the Toll connection. | 1-gen-2006 | Mantovani, A; Garlanda, C | |
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF | 1-gen-2005 | Ricca, I.; Compagno, M.; Ladetto, M.; Rocci, A.; Dell'Aquila, M.; Omedè, P.; De Marco, F.; D'Antico, S.; Caracciolo, D.; Ferrero, D.; Carlo-Stella, C.; Tarella, C. | |
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes | 1-gen-2015 | DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Boveri, E; Ponzoni, M; Malcovati, Luca; Papaemmanuil, E; Rigolin, Gm; Pascutto, C; Croci, G; Gianelli, U; Milani, R; Ambaglio, I; Elena, Chiara; Ubezio, M; Da Via', Mc; Bono, E; Pietra, D; Quaglia, F; Bastia, R; Ferretti, V; Cuneo, A; Morra, E; Campbell, Pj; Orazi, A; Invernizzi, Rosangela; Cazzola, Mario | |
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. | 1-gen-2016 | Locatelli, S L; Careddu, G; Inghirami, G; Castagna, L; Sportelli, P; Santoro, A; Carlo-Stella, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile